Thought Leadership
Email Page
Little Impact Post-Arthrex for Biologic Patents at the PTAB
December 3, 2019
Stacie Ropka, Drew Hillier, and Gabriella McIntyre
The Center for Biosimilars

Axinn partner Stacie Ropka and associates Drew Hillier and Gabriella McIntyre authored The Center for Biosimilars article, "Little Impact Post-Arthrex for Biologic Patents at the PTAB."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.